ACAD
Acadia Pharmaceuticals Inc

13,146
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 05,
After Hours

Estimated EPS

$0.14

Estimated Rev

$276.7M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
$0.14
--
--
N/A
Q2 '25
$0.14
$0.16
15.88%
BEAT
Q1 '25
$0.09
$0.11
26.93%
BEAT
Q4 '24
$0.22
$0.86
298.68%
BEAT
Q3 '24
$0.14
$0.20
44.84%
BEAT

Latest ACAD News

View

Advertisement. Remove ads.

Advertisement. Remove ads.